These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7518966)

  • 21. Interactions of FK506 (tacrolimus) with clinically important drugs.
    Matsuda H; Iwasaki K; Shiraga T; Tozuka Z; Hata T; Guengerich FP
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):57-64. PubMed ID: 8824931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on metabolism of tetramethylpyrazine in system of rat liver microsomes].
    Kuang XD; Li XH; Xiong YQ
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1971-5. PubMed ID: 17348193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
    Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone induces bisallylic hydroxylation of polyunsaturated fatty acids by rat liver microsomes.
    Hörnsten L; Bylund J; Oliw EH
    Arch Biochem Biophys; 1996 Aug; 332(2):261-8. PubMed ID: 8806734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo study of the effects of enrofloxacin on hepatic cytochrome P-450. Potential for drug interactions.
    Vancutsem PM; Babish JG
    Vet Hum Toxicol; 1996 Aug; 38(4):254-9. PubMed ID: 8829341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems in rat liver microsomes.
    Izuishi K; Wakabayashi H; Ohnishi T; Maeta H; Maeba T; Ichikawa Y
    Int J Biochem Cell Biol; 1997 Jun; 29(6):921-8. PubMed ID: 9304807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-C20 epoxide metabolite.
    Lhoëst G; Dieden R; Verbeeck RK; Maton N; Ingendoh A; Latinne D
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1074-81. PubMed ID: 9495869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506).
    Tata PN; Subbotina N; Burckart GJ; Muddiman DC; Gusev AI; Hercules DM; Starzl TE; Venkataramanan R
    Xenobiotica; 2009 Oct; 39(10):757-65. PubMed ID: 19604035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
    Boxenbaum H
    J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of FK 506 and cyclosporine metabolism.
    Christians U; Braun F; Sattler M; Almeidal VM; Linck A; Sewing KF
    Transplant Proc; 1991 Dec; 23(6):2794-6. PubMed ID: 1721280
    [No Abstract]   [Full Text] [Related]  

  • 32. FK 506 inhibition of cyclosporine metabolism by human liver microsomes.
    Omar G; Shah IA; Thomson AW; Whiting PH; Burke MD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):934-5. PubMed ID: 1703356
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA.
    Pichard L; Fabre I; Domergue J; Joyeux H; Maurel P
    Transplant Proc; 1991 Dec; 23(6):2791-3. PubMed ID: 1721279
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase.
    Vincent SH; Wang RW; Karanam BV; Klimko M; Alvaro R; Chiu SH
    Biochem Pharmacol; 1991 May; 41(9):1325-30. PubMed ID: 1708254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450.
    Yoshimura R; Yoshimura N; Kusunose E; Tujino T; Ohyama A; Nakatani T; Kishimoto T
    Transplant Proc; 1992 Aug; 24(4):1395. PubMed ID: 1379755
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 5-fluorocytosine and 5-fluorouracil on human and rat hepatic cytochrome P 450.
    Inselmann G; Holzlöhner U; Heidemann HT
    Mycoses; 1989 Dec; 32(12):638-43. PubMed ID: 2622477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.
    Venkataramanan R; Zang S; Gayowski T; Singh N
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3091-3. PubMed ID: 12183280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes.
    Perotti BY; Prueksaritanont T; Benet LZ
    Pharm Res; 1994 Jun; 11(6):844-7. PubMed ID: 7524055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The influence of volatile anaesthetics on drug metabolism in the liver (author's transl)].
    Hempel V; von Kügelgen C; Remmer H
    Anaesthesist; 1975 Sep; 24(9):400-3. PubMed ID: 1190420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.